Christopher C. Gibson: Hello, and welcome, everybody, to Recursion's Q2 2025 Earnings Call. My name is Chris Gibson, and I'm the Co-Founder and CEO of Recursion. And I'm excited to share with you ...

Today, the value of this approach is widely recognised even by most pharmaceutical companies, a number of which – including Sanofi, Roche and Genentech, Bayer, and Merck KgaA – have partnered with ...

Recursion Pharmaceuticals, Inc ((RXRX)) has held its Q2 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off ...

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) Q4 2023 Earnings Conference Call February 27, 2024 5:00 PM ET Company Participants Chris Gibson - Co-Founder and CEO Conference Call Participants ...

Additionally, Recursion will host its first-ever L (earnings) Call on February 27, 2024 at 5:00 pm Eastern Time / 3:00 pm Mountain Time.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ETCompany ParticipantsChris Gibson - Co-Founder and ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 5,540 calls trading, 2x expected, and implied vol increasing over 2 points to 75.26%. Jan-27 5 calls and Nov-24 8 calls are ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) Q1 2025 Earnings Call Transcript May 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations.